首页 正文

Novel compounds for the treatment of Duchenne muscular dystrophy: emerging therapeutic agents

{{output}}
The identification of dystrophin and the causative role of mutations in this gene in Duchenne and Becker muscular dystrophies (D/BMD) was expected to lead to timely development of effective therapies. Despite over 20 years of research, corticosteroids remain t... ...